Skin & hair

One Spot or the Whole Field?

Save

Actinic keratoses rarely show up alone — the sun damage that produced one visible spot usually produced others nearby that haven't become visible yet. That single fact is most of what decides whether cryotherapy on individual spots or a field-wide topical treatment makes more sense. Here's how dermatologists actually make that call, and what each option involves.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What "Field Cancerization" Means, and Why It Changes the Math

An actinic keratosis is a rough, scaly patch caused by cumulative sun damage, and it's considered a precancerous lesion because a small percentage can progress to squamous cell carcinoma if left untreated. The key fact that shapes treatment choice is that sun damage is rarely limited to the one spot that became visible enough to notice — surrounding skin that looks normal often carries the same early cellular changes, a phenomenon dermatologists call field cancerization, which is why new keratoses tend to keep appearing in the same general area even after the visible ones are treated. Spot treatment addresses only what's currently visible; field treatment is built specifically to address that underlying, not-yet-visible damage across a whole region.

Spot Treatment: Cryotherapy on Individual Lesions

Cryotherapy with liquid nitrogen is the most common destructive, lesion-directed treatment for actinic keratosis: it freezes the abnormal cells in a specific spot, causing the treated area to blister and shed over one to two weeks as new skin forms underneath 1. It's fast — often done in the same visit as the exam that finds the lesion — and it's well suited to someone with just one or a handful of well-defined, easily identified keratoses. Its main drawbacks are that it only treats what's visible on that day, it can leave a temporarily or occasionally permanently lighter patch of skin where it was applied, and treating dozens of individual spots one by one becomes impractical and uncomfortable well before it becomes ineffective 1. A single lesion may be frozen more than once in the same visit, since a longer or repeated freeze reaches deeper into a thicker lesion than one quick pass, which is part of why a thick, well-established keratosis and a faint, early one aren't always treated identically even within the same cryotherapy session 1.

Field Treatment: Covering the Whole Sun-Damaged Area

Actinic keratosis field therapy applies a topical medication — most often 5-fluorouracil, imiquimod, or diclofenac gel — or photodynamic therapy across an entire area, such as the scalp, forehead, or forearm, rather than targeting individual spots 1. Because it treats the whole field, it catches keratoses too small or too faint to see yet, which is the main advantage over cryotherapy for someone with many lesions or a pattern of new ones appearing steadily. The tradeoff is time and tolerance: field treatments typically involve days to weeks of visible redness, peeling, or crusting across the whole treated area as the topical agent does its work, which is a more disruptive process day-to-day than a quick freeze, even though it addresses more territory in one course. Photodynamic therapy is a different route within field treatment: a light-activated treatment for precancers, it involves a photosensitizing solution applied to the skin, left to absorb, then activated with a specific wavelength of light in-office, triggering a reaction that targets damaged cells while sparing normal skin nearby more than a topical course typically does. A rough 5-FU imiquimod PDT comparison comes down to time and setting — the topical agents are used at home over days to weeks with a longer visible reaction, while photodynamic therapy happens in-office in one or a few sessions with a shorter, more concentrated reaction in the days right after treatment.

How to Choose Actinic Keratosis Treatment for a Given Case

How to choose actinic keratosis treatment usually comes down to counting and pattern: a few isolated, well-defined lesions on otherwise lightly damaged skin generally point toward cryotherapy, while numerous lesions, a large area of visibly sun-damaged skin, or a history of keratoses recurring faster than they can be frozen one at a time point toward field therapy. Location matters too — actinic keratosis on scalp treatment often favors field therapy given how much of the scalp tends to be diffusely sun-damaged in someone with significant hair thinning or a history of outdoor work, where counting individual lesions undersells how much of the area is actually affected. Many people end up doing both: field treatment for the broader area, with cryotherapy reserved for any single lesion that's thicker, more tender, or otherwise looks different enough from its neighbors to warrant individual attention rather than the same topical course as everything around it.

Why Actinic Keratosis Comes Back After Either Approach

Actinic keratosis recurrence after treatment is common with both spot and field approaches, and it isn't usually a sign that the treatment failed — it's the same field cancerization at work, since the underlying sun-damaged skin that produced the first keratosis is still there and can keep producing new ones over months or years, particularly with continued sun exposure. This is why a single round of either cryotherapy or field therapy isn't expected to be a one-time fix: ongoing sun protection reduces how quickly new lesions form, and periodic checks of a known sun-damaged area catch new keratoses, or anything that looks like it might be progressing, while they're still easy to treat. That kind of targeted follow-up in someone with a known history of actinic keratosis is a different question from population-wide skin cancer screening, where the evidence for routinely examining asymptomatic adults with no known lesions is still considered insufficient to weigh the balance of benefits and harms 2. Recurrence is a reason for a maintenance rhythm with a dermatologist, not a reason to assume the first treatment was the wrong choice.

Actinic Keratosis on the Lips: A Different Set of Considerations

Actinic cheilitis — actinic keratosis affecting the lips, most often the lower lip — gets treated somewhat differently than skin elsewhere, since lip tissue is thinner, more sensitive, and carries a comparatively higher risk of progressing to squamous cell carcinoma if changes go unaddressed. Both spot and field approaches are used here too, but the choice and the technique tend to be more conservative given how visible and sensitive the area is, and a persistent rough patch, chronic dryness, or a sore on the lip that doesn't heal is generally worth a dermatologist's direct evaluation rather than assuming it's ordinary chapping.

Common questions

Neither is universally "more effective" — they solve different problems. Cryotherapy clears what's currently visible; field therapy addresses the broader area, including damage too faint to see yet. For someone with a handful of isolated lesions, cryotherapy alone may be sufficient. For someone with many lesions or a pattern of recurrence, field therapy typically does more of the actual work.

Yes, and it's common. A typical approach uses field therapy across a broadly sun-damaged area and reserves cryotherapy for any individual lesion that looks thicker, more tender, or otherwise different enough from its neighbors to warrant separate attention rather than the same topical course as the surrounding skin.

Most topical field treatments involve an active course of days to a few weeks, during which the treated area becomes visibly red, peeling, or crusted as it works, followed by healing. The exact course length and expected reaction depend on which topical agent is used and the area being treated.

Because the sun damage that produced the first visible keratosis usually affected a wider area than what was treated — a pattern called field cancerization. New lesions arising later generally reflect that ongoing underlying damage rather than the original treatment having failed.

Coverage details vary by plan and are worth confirming directly with an insurer, but treatment choice should be driven primarily by how many lesions are present and their pattern, not by assumptions about coverage. A dermatologist can usually indicate which approach is medically appropriate before cost becomes part of the conversation.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When a Spot Needs More Than Routine Actinic Keratosis Treatment

  • —A lesion that becomes thick, tender, or rapidly growing rather than staying flat and stable
  • —A spot that bleeds, ulcerates, or fails to heal after treatment
  • —A sore on the lip that persists beyond a few weeks or doesn't respond to conservative care
  • —Any lesion a dermatologist has flagged for biopsy that changes before that appointment

This article is general health information, not medical advice. It cannot determine whether a specific lesion is an actinic keratosis or something requiring biopsy, and it does not replace an in-person evaluation by a dermatologist.

References

  1. 1.American Family Physician (2007). Treatment Options for Actinic Keratoses. American Family Physician. link ✓Review of actinic keratosis treatment options: lesion-directed cryotherapy as the most common destructive therapy, plus field therapies (topical 5-fluorouracil, imiquimod, diclofenac) and photodynamic therapy; supports cryotherapy indications, technique, and adverse effects (hypopigmentation), and field therapy's role in treating subclinical disease.
  2. 2.US Preventive Services Task Force (2023). Skin Cancer: Screening. US Preventive Services Task Force. link ✓USPSTF final recommendation (2023, Grade I): current evidence is insufficient to assess the balance of benefits and harms of routine clinician whole-body skin examination to screen asymptomatic adults for skin cancer; used here only to distinguish population-wide screening from targeted follow-up of a known, previously diagnosed sun-damaged area, which this recommendation does not address.

2 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy

← Back to the health library